You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

childhood acute promyelocytic leukemia (M3)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Childhood Acute Promyelocytic Leukemia (M3), Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Trial in

Active, not recruiting
Has Results
  • Childhood Acute Promyelocytic Leukemia (M3)
  • Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
  • arsenic trioxide
  • +7 more
  • Birmingham, Alabama
  • +110 more
Mar 23, 2022

The Relapses in Childhood Acute Lymphoplastic Leukemia Excluding

Completed
  • Leukemia, Acute
    • (no location specified)
    Jul 23, 2023

    DNA Samples From Acute Lymphoblastic Leukemia or Acute Myeloid

    Completed
    • Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
    • +8 more
    • Laboratory Biomarker Analysis
    • Philadelphia, Pennsylvania
      Childrens Oncology Group
    Jul 12, 2022

    Acute Promyelocytic Leukemia Trial in United States (SY-2101, Arsenic Trioxide)

    Recruiting
    • Acute Promyelocytic Leukemia
    • Birmingham, Alabama
    • +4 more
    Jul 12, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

    Active, not recruiting
    • Acute Lymphoblastic Leukemia
    • +15 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Chicago, Illinois
    • +2 more
    Jan 12, 2023

    Blastic Phase, Childhood Acute Promyelocytic Leukemia With PML-RARA, Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive

    Completed
    Has Results
    • Blastic Phase
    • +9 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Birmingham, Alabama
    • +24 more
    Jan 13, 2021

    CBFA2T3-GLIS2-positive Acute Myeloid Leukemia, AML, Childhood, Relapsed Pediatric AML Trial (ELU001)

    Not yet recruiting
    • CBFA2T3-GLIS2-positive Acute Myeloid Leukemia
    • +3 more
    • (no location specified)
    Nov 14, 2022

    Acute Myeloid Leukemia (AML) Trial in Austria, Italy, Spain (Ivosidenib Oral Tablet, Azacitidine)

    Not yet recruiting
    • Acute Myeloid Leukemia (AML)
    • Vienna, Austria
    • +3 more
    Jun 8, 2023

    Acute Myeloid Leukemia, Adult Trial in Hangzhou (cladribine + homoharringtonine + cytarabine)

    Recruiting
    • Acute Myeloid Leukemia, Adult
    • cladribine + homoharringtonine + cytarabine
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital, Zhejiang University School of Med
    Jun 13, 2023

    Acute Promyelocytic Leukemia Trial in Xi'an (Realgar-Indigo naturalis formula, all-trans retinoic acid, Arsenic trioxide)

    Recruiting
    • Acute Promyelocytic Leukemia
    • Realgar-Indigo naturalis formula
    • +3 more
    • Xi'an, Shaanxi, China
      First Affiliated Hospital of Xi'an Jiaotong University
    Aug 31, 2021

    Leukemia Trial in Tianjin (DNR:, Ara-c)

    Completed
    Has Results
    • Leukemia
    • Tianjin, Tianjin, China
    • +1 more
    Aug 8, 2021

    ACUTE LYMPHOBLASTIC LEUKEMIA Trial (Inotuzumab ozogamicin, ALLR3)

    Not yet recruiting
    • ACUTE LYMPHOBLASTIC LEUKEMIA
    • (no location specified)
    Feb 17, 2023

    Acute Myeloid Leukemia in Remission, FLT3 Gene Mutation, Hematologic and Lymphocytic Disorder Trial in Houston (Azacitidine,

    Recruiting
    • Acute Myeloid Leukemia in Remission
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 13, 2022

    Hematopoietic and Lymphoid Cell Tumor, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Myeloid Leukemia Trial in Houston

    Recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 31, 2022

    AML, Childhood Trial in United States (CD33*CD3 BsAb)

    Active, not recruiting
    • AML, Childhood
    • CD33*CD3 BsAb
    • Birmingham, Alabama
    • +12 more
    Jan 12, 2023

    FLT3 Gene Mutation Negative, FLT3 Internal Tandem Duplication Positive, Recurrent Acute Myeloid Leukemia Trial in Houston

    Active, not recruiting
    • FLT3 Gene Mutation Negative
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 16, 2022

    Leukemia, Myeloid, Acute Trial in Worldwide (CC-90009, Venetoclax, Azacitidine)

    Recruiting
    • Leukemia, Myeloid, Acute
    • San Francisco, California
    • +25 more
    Jan 9, 2023

    Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia Trial in Seattle (Cladribine, Cytarabine,

    Recruiting
    • Acute Biphenotypic Leukemia
    • +11 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 18, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

    Recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +7 more
    • Blinatumomab
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 31, 2022

    Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6) Trial in

    Completed
    Has Results
    • Childhood Acute Basophilic Leukemia
    • +14 more
    • Phoenix, Arizona
    • +96 more
    Jan 20, 2022

    Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

    Terminated
    Has Results
    • Acute Biphenotypic Leukemia
    • +29 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 4, 2023

    Leukemia Trial in Austria, Germany, Italy (arsenic trioxide, idarubicin, mercaptopurine)

    Completed
    • Leukemia
    • arsenic trioxide
    • +5 more
    • Innsbruck, Austria
    • +109 more
    Oct 10, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine and

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Decitabine and Cedazuridine
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Apr 19, 2022

    Leukemia, Myeloid, Acute, MDS Trial in Worldwide (CC-90009)

    Recruiting
    • Leukemia, Myeloid, Acute
    • Myelodysplastic Syndromes
    • New Haven, Connecticut
    • +23 more
    Aug 1, 2022

    MT2017-45: CAR-T Cell Therapy for Heme Malignancies

    Recruiting
    • Acute Lymphoblastic Leukemia
    • Large B-cell Lymphoma
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Nov 2, 2022